News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Drug Product News (World)
Mylan (MYL) Launches Generic Apresoline Injection 5/5/2016
Grand Cayman Will Use Oxitec Solution To Suppress Wild Aedes Aegypti, The Dangerous Mosquito That Spreads Dengue, Zika And Chikungunya, In An Effort To Help Eliminate These Diseases 5/5/2016
Takeda Pharmaceuticals Release: Brintellix (Vortioxetine) Renamed Trintellix (Vortioxetine) In U.S. To Avoid Name Confusion 5/3/2016
Perrigo (PRGO) And Allergan (AGN) Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex 1200mg DM Extended-Release Tablets 5/3/2016
Dynavax (DVAX)'s Possible Hep B Win Could Prove a Threat to GlaxoSmithKline (GSK) 5/3/2016
Merck Canada Inc. Release: New Treatment Now Available For Canadians With Metastatic Non-Small Cell Lung Cancer 4/20/2016
Promius Pharma, LLC Release: ZEMBRACE Symtouch (Sumatriptan Injection) 3 Mg, Approved By The FDA In January 2016 For The Acute Treatment Of Migraine With Or Without Aura In Adults, Is Now Commercially Available In The U.S. 4/19/2016
PTC Therapeutics (PTCT) Release: National Institute for Clinical Excellence (NICE) Recommends Translarna (Ataluren) For The Treatment Of Patients With Nonsense Mutation Duchenne Muscular Dystrophy In England 4/15/2016
Why Chinese Parents Are Shopping For Vaccines In Hong Kong 4/13/2016
Martindale Pharma Launches First Ready-To-Use Presentation Of Phenylephrine 4/12/2016
GE Healthcare Expands European Capabilities To Support Accelerated Biomanufacturing 4/12/2016
Midatech’s Commercial Launch Of Zuplenz (Ondansetron) Oral Soluble Film To Prevent Post-Operative, Chemotherapy And Radiation-Induced Nausea And Vomiting In U.S. 4/11/2016
Cipher Pharma (DND.TO) Announces Canadian Launch Of Beteflam 4/6/2016
Lupin (LUPN.BO) Launches Generic Intermezzo Sublingual Tablets In The US 4/6/2016
BTG plc (BTG.L) Announces US Launch Of LC Bead LUMI, Ground-Breaking Radiopaque Embolic Bead 4/1/2016
Biofrontera AG Release: Swiss Compulsory Health Insurance Reimburses Ameluz For Treatment Of Actinic Keratosis 4/1/2016
SELLAS Receives USAN Approval For Generic Name Of Galinpepimut-S For WT1 Vaccine, SELLAS's Late Clinical-Stage Cancer Immunotherapy Candidate 3/29/2016
7 Potential Blockbuster Drugs May Hit the Market This Year 3/28/2016
Birth Of The $1 Diarrhea Vaccine 3/28/2016
China's Vaccine Scandal Reveals System's Flaws 3/25/2016
Profounda, Inc. Launches Impavido (miltefosine), The First And Only Oral Rx Treatment For Visceral, Mucosal And Cutaneous Leishmaniasis, In The United States 3/22/2016
$90 Million China Vaccine Scandal Prompts Angry Backlash From Parents And Doctors 3/22/2016
Teva (TEVA) Announces Launch Of Generic Campral® In The United States 3/22/2016
Martindale Pharma Re-Launches Methadone Range In Scandinavia 3/21/2016
BTG International Canada Expands Operations To Directly Sell Interventional Oncology Products 3/10/2016
Teva (TEVA) Completes Generic Pulmicort Respules Portfolio With The Launch Of Third Strength In The United States 3/9/2016
Zika Virus Guidance From FDA Notes Safety Of Plasma Protein Products And The Availability Of Octapharma AG’s Octaplas 3/7/2016
How a $150,000 Drug Created with Bristol-Myers Squibb (BMY) Saved Ono Pharma 3/7/2016
Altan Pharma Announces The Launch Of Linezolid 2mg/Ml Solution For Infusion In Spain 3/3/2016
Health Canada Issues Notice Of Compliance For Gilead (GILD)'s Truvada For Reducing The Risk Of Sexually Acquired HIV Infection 2/29/2016
Zambon Launches Xadago (Safinamide) In Italy For Patients With Mid- To Late-Stage Parkinson’s Disease 2/29/2016
Adapt Pharma Release: NARCAN (Naloxone Hydrochloride) NASAL SPRAY Now Available In The United States For Emergency Treatment Of Known Or Suspected Opioid Overdose 2/26/2016
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine Recognized As A New Option With Demonstrated Superior Efficacy* For Adults 65 Years And Older 2/24/2016
Sanofi US (SNY) To Return Auvi-Q (epinephrine injection, USP) Rights To Kaleo 2/24/2016
GlaxoSmithKline (GSK) President’s "Eight Terrifying Words" Face Systemic Challenges in U.S. 2/24/2016
CSL Behring Release: First Export Of Privigen From New Manufacturing Facility In Broadmeadows, Melbourne, Australia 2/23/2016
Merck Canada Inc. Release: New Antibiotic Against Drug-Resistant Bacteria Now Available 2/22/2016
Lipogen Ltd. Targets PMS/PMDD Relief, Naturally 2/22/2016
Specialised Therapeutics Asia To Distribute Novel Multiple Myeloma Drug APLIDIN In South East Asia, Australia And New Zealand 2/3/2016
Lupin (LUPN.BO) Launches Generic Glumetza HCI ER Tablets In The US 2/2/2016
Sinovac Biotech Ltd. (SVA) Announces Issuance Of GMP Certificate For EV71 Vaccine 1/28/2016
Teva (TEVA) And Eagle Pharma (EGRX) Announce Commercial Availability Of BENDEKA (Bendamustine Hydrochloride) Injection 1/28/2016
Cardiome Pharma Corp. (COM.TO) Announces The Launch Of ESMOCARD LYO In Belgium 1/21/2016
Off Label Use of Roche (RHHBY)’s Avastin in India Puts 15 in the Hospital, Prompts Officials to Halt Using the Drug 1/21/2016
Mylan (MYL) Launches Generic Harvoni (Ledipasvir/Sofosbuvir) Under The Brand Name Myhep LVIR In India 1/7/2016
EffRx: First-In-Class Osteoporosis Treatment Binosto Launches In South Korea 1/7/2016
Lupin (LUPN.BO) Launches Generic Ortho Tri-Cyclen Lo Tablets In The US 1/6/2016
Mylan (MYL) Launches Generic Ortho Tri-Cyclen Lo Tablets 1/5/2016
Teva (TEVA) Announces Launch Of Generic Ortho Tri-Cyclen Lo In The United States 1/5/2016
Bioventus Launches DUROLANE For Osteoarthritis Patients In Taiwan 1/4/2016
Turing Release: Continued Availability Of Daraprim (pyrimethamine) 12/21/2015
Pharming And Hyupjin Announce Receipt Of The South Korean Marketing Authorization For RUCONEST 12/21/2015
TaiGen Biotechnology Launches Taigexyn In Taiwan 12/16/2015
Endo International (ENDP) Announces Extension Of U.S. Rights For Voltaren Gel 12/14/2015
ALK-Abello A/S Release: New Product Product (ACARIZAX) For For Treatment Of House Dust Mite Allergic Rhinitis And Asthma Obtains Reimbursement In Denmark 12/9/2015
Veloxis Pharmaceuticals A/S (VELO) Launches EnvarsusXR For Treatment Of Kidney Transplant Patients In U.S. 12/7/2015
United Laboratories Inc. And Debiopharm Announce The Launch Of Pamorelin LA In The Philippines 12/7/2015
Ruizhida From China Launched Its New Line Of Acne Treatment Products 12/3/2015
Bio Products Laboratory Announces Supply Of COAGADEX Now Available In The United States 12/3/2015
Sanofi (SNY) Creeps Up On Biogen (BIIB)’s MS Market Share 12/2/2015
TB Alliance And Partners Announce World's First Availability Of Appropriate, Child-Friendly TB Medicines In Correct Doses 12/2/2015
Mesoblast (MSB.AX)’s Japan Licensee Receives Pricing For TEMCELL HS Inj. For Treatment Of Acute Graft Versus Host Disease 11/30/2015
Mylan (MYL) Launches Generic FazaClo Orally Disintegrating Tablets 11/24/2015
Cumberland Pharmaceuticals (CPIX) Release: Caldolor Launched In Australia For Treatment Of Pain And Fever 11/24/2015
CVS Picks Amgen (AMGN)'s Repatha Over Sanofi (SNY)-Regeneron (REGN)'s Cholesterol Drug 11/23/2015
Mylan (MYL) Launches Generic AXERT Tablets 11/17/2015
AstraZeneca PLC (AZN)'s Lung Cancer Pill and Its Hefty Price Tag 11/17/2015
Mylan (MYL) Launches Generic Viramune XR Extended-Release Tablets, 100 mg 11/16/2015
Novartis AG (NVS)'s Japanese Unit in Trouble Again for Failing to Report Drug Side Effects on Time 11/12/2015
Mallinckrodt (MNK) Plunges After Citron Claims Next Victim in Tweet 11/11/2015
Pfizer Canada Inc. Release: Update on Availability Of EpiPen (epinephrine) Auto-Injectors For Canadian Patients 11/9/2015
Admedus Announces Launch Of Cardiocel In Malaysia 11/4/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared 11/4/2015
Bespak plc (BPK.L) Launches Syrina 2.25 Auto Injector And Leads Industry Workshop On Innovation In Combinational Products At PDA Europe 11/2/2015
Mylan (MYL) Confirms Availability of EpiPen (epinephrine injection) Auto-Injector For U.S. Patients Affected By Sanofi (SNY)'s Auvi-Q (Epinephrine Injection, USP) Recall 10/30/2015
AstraZeneca Canada (AZN) Release: DUAKLIR GENUAIR Now Available In Canada For The Treatment Of Chronic Obstructive Pulmonary Disease 10/29/2015
BioPharm Executive: From Bad to Worse: Biotech's Next Political Headache? 10/29/2015
Oasmia Executes First Commercial Order Of Paclical For The Russian Market 10/28/2015
Bavarian Nordic (BAVA.CO) Announces Expansion Of IMVAMUNE Orders From Canadian Government 10/28/2015
Mundipharma AG Release: Green Whistle Receives Regulatorry And Marketing Approval In The United Kingdom 10/28/2015
Novozymes Release: New Enzyme Boosts Profits, Cuts Chemical Use At Ethanol Plants 10/27/2015
AstraZeneca Canada (AZN) Launches New FluMist® Quadrivalent Flu Vaccine For This Flu Season 10/26/2015
The Native Antigen Company Limited (‘NAC’: Oxford, UK) Announces The Launch Of A New Range Of Dengue Virus-Like Particles Incorporating Products For All Four Dengue Serotypes. 10/22/2015
Hired By Huge Drug Companies Like Eli Lilly (LLY), Ex-Cop in London Tracks Down Knockoff Drugs on the Web 10/21/2015
Allergan (AGN) Expands Dry Eye Portfolio With Launch Of REFRESH OPTIVE Gel Drops 10/21/2015
Teva (TEVA) Announces Exclusive Launch Of Generic Avodart Capsules In The United States 10/12/2015
Oasmia Announces Commercial Launch Of Paclical In Russia And CIS Countries 10/5/2015
Roche Canada Release: Biologic Treatment Option Now Available To Canadian Women Living With Advanced Ovarian Cancer 10/5/2015
Lupin (LUPN.BO) Hikes Diabetes Drug Price by 200% in the U.S. 9/25/2015
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries 9/24/2015
Complaints for Bayer AG (BAYZF)'s Sterility Device Spike Nearly 1,400% in Three Years 9/22/2015
Turing Pharma’s Toxoplasmosis Treatment Spikes 5,000% Overnight 9/22/2015
ibidi Product News: Ibidi µ-Slide 8 Well Grid-500: Track Down Your Cells In A µ-Slide 8 Well 9/21/2015
Information Update - Health Canada Proposes Revised Labelling Standard For Non-Prescription Acetaminophen Products 9/16/2015
Mylan (MYL) Launches Generic Unasyn For Injection 9/14/2015
Allergan (AGN) Expands Access To IUDs For Millions Of Underserved Women In The US By Announcing Agreement With Apexus For Nationwide Distribution Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg 9/10/2015
Vernalis Therapeutics Launches Long-Acting Codeine-Based Cough Suppressant Ahead Of U.S. Cough Cold Season 9/8/2015
Roche (RHHBY) Chief Blasts U.K. Decision to Not Cover Costs of Some Cancer Treatments 9/8/2015
Novartis AG (NVS) Takes on Amgen (AMGN) With Launch of the First U.S. Biosimilar 9/4/2015
Allergan (AGN) Announces FDA Approval Of Updated Label For TEFLARO (ceftaroline fosamil) 9/2/2015
Laccure's Antibiotic-Free OTC Product For Bacterial Vaginosis Ready For Commercialisation 9/1/2015
Teva (TEVA) Announces U.S. Availability Of ZECUITY (Sumatriptan Iontophoretic Transdermal System), First And Only Transdermal Patch System For The Acute Treatment Of Migraine 9/1/2015
Endo Pharmaceuticals (ENDP) Announces XIAFLEX For Dupuytren's Contracture Formal Pricing In Japan; Commercial Launch Set For September 16, 2015 8/31/2015
BioSpecifics Technologies Corporation (BSTC) Announces Formal Pricing Of XIAFLEX For The Treatment Of Dupuytren's Contracture In Japan 8/31/2015
Generex Biotechnology Corporation (GNBT) Announces Issuance of Buccal Insulin White Paper 8/27/2015
ReproCELLl: Joint Press Announcement With Institute For Frontier Medical Sciences, Kyoto University 8/26/2015
Hospira Release: TGA Approves First mAb Biosimilar 8/20/2015
Endo International (ENDP) Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property 8/17/2015
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of PRAMIPEXOLE Dihydrochloride Extended-Release Tablets 8/12/2015
Fight Intensifying Over Which Patients Will Get Regeneron (REGN), Sanofi (SNY)'s $15,000 a Year Cholesterol Drug 8/12/2015
Innova Biosciences Introduces Range Of Conjugated Antibodies 8/10/2015
Watchdog Accuses Pfizer (PFE) of Overcharging By Millions for Epilepsy Drug 8/6/2015
Hetero Announces The Launch Of Biosimilar Rituximab (MABALL) In India 8/5/2015
Omeros Corporation (OMER) Release: Omidria Approved For Commercialization Throughout The European Union And Additional Countries 8/3/2015
Boehringer Ingelheim Welcomes The Inclusion Of OFEV (Nintedanib*) In The Updated International Treatment Guidelines For Idiopathic Pulmonary Fibrosis (IPF) 7/15/2015
Daiichi Sankyo Release: New Therapy To Help Heart Rhythm Patients Means Doctors Are "Spoilt For Choice" 7/10/2015
SANTEN Launches TAPTIQOM Preservative-Free Fixed Combination Eye Drops In The UK 7/10/2015
EXCLUSIVE: Ironwood (IRWD), AstraZeneca PLC (AZN) IBS-C Drug Will File in China Next Year, CEO Tells BioSpace (DHX) 7/9/2015
Teva (TEVA) First To Receive Approval And Launch Generic Axert Tablets In The United States 7/9/2015
Consumer Watchdog Asks FDA to Revoke Approval of Sanofi (SAN.PA)'s Seprafilm 7/8/2015
Novo Nordisk A/S (NVO) Pulls Tresiba Off Shelves in Germany 7/2/2015
Teva (TEVA) Launches Generic Aggrenox Capsules In The United States 7/1/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Polydrug Laboratories Due To Data Integrity Concerns 6/25/2015
TissueGene, Inc. Announces FDA Acceptance Of Invossa As Proprietary Name For TissueGene-C 6/24/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Zhejiang Hisun Pharma Due To Data Integrity Concerns 6/16/2015
Pfizer Consumer Healthcare (PFE) Breaks Ground On $95 Million China Facility 6/15/2015
Mylan (MYL) Launches First Bioequivalent Alternative To Combination Asthma Therapy Seretide Evohaler (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla In The UK 6/8/2015
Mylan (MYL) Launches Generic Version Of Seasonique Tablets 6/3/2015
Boehringer Ingelheim Release: National Institute for Clinical Excellence (NICE) Recommends VARGATEF (Nintedanib*) In Combination With Docetaxel As An Option For Patients With Non-Small Cell Lung Cancer Of Adenocarcinoma Histology Within Its Licensed Indication 6/3/2015
Cipher Pharma (DND.TO) Strengthens Leadership Team With Key Executive Appointments And Announces Launch Of Vaniqa In Canada 6/2/2015
Teva (TEVA) Enhances ADHD Product Line With Generic INTUNIV In The United States 6/2/2015
Teva (TEVA) Enhances Extensive Women’s Health Portfolio With Launch of Generic Lomedia 24 Fe Tablets 5/29/2015
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself 5/28/2015
S-BIO Launching BlotGlyco O-Glycan Sample Preparation Kit In U.S., Japan 5/19/2015
Endo International (ENDP) Announces Updated XIAFLEX Label With Recurrence And Retreatment Data In Patients With Dupuytren's Contracture 5/18/2015
Actavis (ACT) Launches NAMZARIC (memantine hydrochloride Extended-Release And donepezil hydrochloride), A Fixed-Dose Combination Therapy For The Treatment Of Moderate To Severe Alzheimer's Disease 5/18/2015
BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel Under The New Trademark HPO Skin Protect Owned By Centro Internacional De Cosmiatria, S.A.P.I. De C.V. ("FARMAPIEL") In Mexico 5/18/2015
Zambon Launches Xadago (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany 5/15/2015
Hikma Pharmaceuticals (HIK.L) Launches Caffeine Citrate Injection, Commercialising The First Of The Bedford Products 5/12/2015
Beike Biotechnology Produces High-Dose Adult Stem Cell Packets For Degenerative Conditions 5/6/2015
Mylan (MYL) Launches Generic Seasonale Tablets 5/5/2015
Mylan (MYL) Launches Gilead (GILD)' Sovaldi Tablets In India 5/4/2015
AOP Orphan Pharmaceuticals AG Launches Lojuxta (Lomitapide) For Treatment Of Homozygous Familial Hypercholesterolaemia To The Austrian Market 4/30/2015
Teva (TEVA) Launches Generic Abilify Tablets In The United States 4/29/2015
Teva (TEVA) Continues To Invigorate Injectable Portfolio With The Launch Of Argatroban Injection In The United States 4/28/2015
Actavis (ACT) Launches AVYCAZ (Ceftazidime-Avibactam) Anti-Infective In U.S. 4/23/2015
Perrigo (PRGO) Announces The Launch Of A Generic Version Of Kenalog Nasal Spray 4/17/2015
FDA Panel Wants Heart Risk Warnings for AstraZeneca PLC (AZN), Takeda (TKPYY) Diabetes Drugs 4/16/2015
Pharma Giant GlaxoSmithKline (GSK) to Battle Rowex Over Purple Design of a New Inhaler 4/15/2015
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-releasing intrauterine system) 52 Mg To Prevent Pregnancy For Up To Three Years 4/14/2015
Sanofi (SAN.PA) Korea Launches Anlit Probiotic Supplement For Kids 4/14/2015
Sanofi (SAN.PA) Stuck Between a Rock and a Hard Place With Lantus Heir Toujeo 4/13/2015
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-Releasing Intrauterine System) 52 Mg To Prevent Pregnancy For Up To Three Years 4/13/2015
European Medicines Agency's PRAC Recommends Updating Advice On Use Of High Dose Ibuprofen 4/13/2015
Alexion (ALXN) Receives Approval For Important Updates To The European Label For Soliris (Eculizumab) 4/10/2015
Why the Flu Vaccine Barely Worked This Year 4/8/2015
Perrigo (PRGO) Announces FDA Approval And Upcoming Launch Of The AB Therapeutic Equivalent To Exalgo 4/8/2015
Mylan (MYL) Launches First Generic Version Of Generess Fe 4/7/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Novartis AG (NVS) Accused of "Bullying" Doctors to Drop Trial of Cheaper Drugs 4/6/2015
Pfizer (PFE) Halts China Vaccine Business After Import License is Killed; 200 Employees Impacted 4/3/2015
Merck & Co. (MRK)'s HPV Vaccine, GARDASIL9, Now Available In Canada 4/1/2015
Mylan (MYL) Launches Generic Exforge Tablets 3/31/2015
PHEBURANE Now Available For Distribution In Canada Through Medunik Canada 3/30/2015
Hospira's INFLECTRA (Infliximab) Now Available In Canada 3/30/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Neovasc Inc. (NVC) Launches Reducer In Select European Countries 3/20/2015
Hatchtech Pty Ltd To Explore Strategic Alternatives For Commercialization Of Xeglyze Lotion In The U.S. 3/18/2015
Actavis (ACT) Receives FDA Approval For VIIBRYD (vilazodone HCl) 20mg Once Daily As A Therapeutic Dose 3/17/2015
Duchesnay inc. Release: Expansion Overseas – Diclectin For Nausea And Vomiting Of Pregnancy (NVP) Now Available In Israel 3/17/2015
Endo Pharmaceuticals (ENDP) Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy 3/16/2015
Yisheng Biopharma Co., Ltd. Release: A New Therapeutic Vaccine Successfully Developed Against Rabies 3/16/2015
Advisory - Jamp Pharma Corp Recalls Jamp-Methotrexate (USP 50mg/2mL) Due To Particulate Matter 3/16/2015
Genovis Is Launching A New Enzyme Product 3/12/2015
Mylan Inc. (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Fentanyl Transdermal System 37.5, 62.5 And 87.5 Mcg/Hr 3/11/2015
Mylan Inc. (MYL) Launches Generic Antabuse Tablets 3/11/2015
Take Charge And Become One Of The Alpha Elite With The Launch Of Hantian Labs' Stimulant Free Testosterone And Performance Booster 3/11/2015
Mylan Inc. (MYL) Launches Generic Subutex Sublingual Tablets 3/11/2015
Vectura Group plc (VEC.L) Release: AirFluSal Forspiro Launched In Portugal And Ireland 3/11/2015
Milan, Italy: BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel In The People's Republic Of China By Luqa Pharmaceuticals 3/10/2015
TWi Pharmaceuticals, Inc. Receives Rare Disease Drug Designation For Its Drug Candidate AC-203 In Taiwan 3/10/2015
Actavis (ACT) Launches Generic Version Of Temovate (Clobetasol Cream 0.05%) 3/9/2015
Ipsen (IPN.PA) Announces Third Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S. In 2015 3/2/2015
Celltrion, Inc. (068270.KQ) Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets 2/25/2015
TWi Pharmaceuticals, Inc. Announces That It Will Sell Its Products In The U.S. Market, Originally Planned To Be Sold By Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA 2/24/2015
Celgene International Sárl (CELG) Release: ABRAXANE Now Reimbursed In Italy As A First-Line Treatment Of Adult Patients With Metastatic Pancreatic Cancer 2/24/2015
Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy 2/20/2015
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015
Teva Pharmaceutical Industries (TEVA) Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States 2/17/2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) Inflectra (Infliximab) In Major European Markets 2/16/2015
Teijin Limited Release: Small-sized MUCOSOLVAN L Expectorant Tablet 45 Mg Approved In Japan 2/16/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Ex-Smokers Jittery About GlaxoSmithKline (GSK)'s Nicorette Lozenge Shortage 2/11/2015
BMG Pharma S.r.l Obtained A New Indication On Molluscum Contagiosium For CE Marked Proprietary Product Ialuxid Gel 2/9/2015
Daiichi Sankyo (4568.t) Release: SAVAYSA (edoxaban) Now Available In U.S. Pharmacies 2/9/2015
Tianjin Medical University Cancer Hospital Release: Nanocarrier Drugs for Pancreatic Cancer Now Being Produced In China 2/6/2015
Novartis Pharmaceuticals Canada Inc. Release: Now Available In Quebec, Ultibro® Breezhaler®, A Once-Daily Dual Bronchodilator For Chronic Obstructive Pulmonary Disease (COPD) 2/3/2015
Sanofi (SAN.PA) And MannKind Corporation (MNKD) Announce Afrezza®, The Only Inhaled Insulin, Now Available In The U.S. 2/3/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/29/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/28/2015



//-->